• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION OBTRYX II SYSTEM - HALO; MESH, SURGICAL, SYNTHETIC, UROGYNECOLOGIC, FOR STRESS URINARY INCONTINENCE, RETR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION OBTRYX II SYSTEM - HALO; MESH, SURGICAL, SYNTHETIC, UROGYNECOLOGIC, FOR STRESS URINARY INCONTINENCE, RETR Back to Search Results
Model Number M0068505110
Device Problem Material Integrity Problem (2978)
Patient Problems Erosion (1750); Urinary Incontinence (4572)
Event Date 12/20/2021
Event Type  Injury  
Manufacturer Narrative
Block b3: the exact event onset date is unknown.The provided event date of (b)(6) 2021, was chosen as the best estimate based on the date of the revision surgery.Block e1: this event was reported by the patient's legal representation.The implant surgeon is: (b)(6).Block h6: imdrf patient code e2006 captures the reportable event of erosion of mesh into the ureterovesical junction.Imdrf impact code f1905 captures the reportable event of removal of trans obturator tape sling.
 
Event Description
It was reported to boston scientific corporation that an obtryx ii system - halo device was used during a trans obturator tape (tot) and cystoscopy procedure performed on (b)(6) 2021, for the treatment of stress urinary incontinence.On (b)(6) 2021, a 49-year-old female patient underwent a trans obturator tape (tot) and cystoscopy procedure to treat her stress urinary incontinence.A small incision was made below the urethra, and this was undermined to the inferior ramus of the pubic bone on both sides.Punctures were made over the medial aspect of the obturator foramen bilaterally.The procedure was then completed with no complications and the patient was reported to be in stable condition.On (b)(6) 2021, aside from the previous stress urinary incontinence, the patient was diagnosed with failed trans obturator tape sling.She then underwent a urethral suspension sling cysto, urethrolysis, removal of the trans obturator sling and repair of the erosion at the ureterovesical junction.During the procedure, there was an erosion channel at the urethrovesical junction that did not break the mucosal surface.This was oversewn with 3-0 chromic suture in the running fashion.A new sling was placed without difficulty.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
OBTRYX II SYSTEM - HALO
Type of Device
MESH, SURGICAL, SYNTHETIC, UROGYNECOLOGIC, FOR STRESS URINARY INCONTINENCE, RETR
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
300 boston scientific way
marlborough MA 01752
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
780 brookside drive
spencer IN 47460
Manufacturer Contact
carole morley
300 boston scientific way
marlborough, MA 01752
5086834015
MDR Report Key17651097
MDR Text Key322291226
Report Number3005099803-2023-04609
Device Sequence Number1
Product Code OTN
UDI-Device Identifier08714729837565
UDI-Public08714729837565
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K121754
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Consumer
Reporter Occupation Other
Type of Report Initial
Report Date 08/30/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received08/30/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date05/20/2022
Device Model NumberM0068505110
Device Catalogue Number850-511
Device Lot Number0023830243
Was Device Available for Evaluation? No
Date Manufacturer Received08/03/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured05/21/2019
Is the Device Single Use? Yes
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age49 YR
Patient SexFemale
-
-